MAGEA1 and cancer: For instance, Krishnadas et al. applied MAGE-A1, MAGE-A3, and NY-ESO-1 peptides-pulsed DC vaccine in children with neuroblastoma or sarcoma in combination with decitabine for cancer treatment [163].